BriaCell Therapeutics Corp. (NASDAQ: BCTX) is 1.44% higher on its value in year-to-date trading and has touched a low of $2.89 and a high of $12.95 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The BCTX stock was last observed hovering at around $3.80 in the last trading session, with the day’s gains setting it 0.43%.
Currently trading at $4.23, the stock is 15.87% and -1.20% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.92 million and changing 11.32% at the moment leaves the stock -38.81% off its SMA200. BCTX registered -77.40% loss for a year compared to 6-month loss of -37.70%. The firm has a 50-day simple moving average (SMA 50) of $4.6779 and a 200-day simple moving average (SMA200) of $4.3739.
The stock witnessed a 34.29% gain in the last 1 month and extending the period to 3 months gives it a 11.90%, and is 21.55% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.92% over the week and 10.18% over the month.
Distance from 52-week low is 46.37% and -67.33% from its 52-week high.
BriaCell Therapeutics Corp. (BCTX) Top Institutional Holders
5 institutions hold shares in BriaCell Therapeutics Corp. (BCTX), with 184.84k shares held by insiders accounting for 23.94% while institutional investors hold 49.33% of the company’s shares. The shares outstanding are 0.77M, and float is at 0.44M with Short Float at 8.17%. Institutions hold 37.52% of the Float.